<< Use of computer-assisted drug design in drug discovery | Eradicating polio a better option than extended control of the disease >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Filipino | Русский | Svenska | Polski

Transplant patients suffering from anemia have a greater mortality rate

Published on April 15, 2007 at 5:58 AM · No Comments

According to a new study in American Journal of Transplantation, kidney transplant patients suffering from anemia, a treatable blood deficiency, are more likely to die or suffer from organ failure than other transplant recipients.

"During a four year period following kidney transplantation, we found that anemic patients were 70 percent more likely to die following their transplant, and two and a half times more likely to again require dialysis," says study author Dr. Istvan Mucsi.

Anemia affects a large number of transplant recipients. "Between 15,000 and 20,000 transplant patients in the U.S. are likely to have severe enough anemia to be treated for it, but it is likely that only a fraction of patients actually receive treatment," says Dr. Mucsi.

It is currently unknown if treating anemia in kidney transplanted patients would improve patient survival; further research is needed. "In the interim, we believe it is prudent to focus more on the diagnosis of post-transplant anemia and also to apply appropriate guidelines that are available for its treatment in chronic kidney disease patients not yet requiring dialysis," says Dr. Mucsi.

http://www.blackwellpublishing.com

Posted in: Drug Trial News

Tags: , , ,

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading